Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
external beam radiation therapy to the prostate, receiving a total dose of 3000 cGy delivered in 15 fractions
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Follow-up abdominal and urinary tract ultrasound examinations at 1week, 1month, and 4months post-radiotherapy showed marked tumor regression with no signs of recurrence. This report aims to share the treatment experience of this case, hoping to provide insights for clinicians.
This report describes a clinically rare case of early-stage primary extranodal marginal zone B-cell lymphoma of the prostate.
APA
Gao X, Wang X, et al. (2026). Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.. Frontiers in oncology, 16, 1721390. https://doi.org/10.3389/fonc.2026.1721390
MLA
Gao X, et al.. "Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.." Frontiers in oncology, vol. 16, 2026, pp. 1721390.
PMID
41847690
Abstract
This report describes a clinically rare case of early-stage primary extranodal marginal zone B-cell lymphoma of the prostate. A 73-year-old male presented with urinary hesitancy. Physical examination revealed mild prostatic enlargement. Prostate biopsy, immunohistochemistry, and genetic testing strongly suggested mucosa-associated lymphoid tissue (MALT) lymphoma. Bone marrow aspiration indicated no bone marrow involvement. Positron Emission Tomography-Computed Tomography (PET-CT) and Emission Computed Tomography (ECT) scans showed no evidence of involvement in other sites. Ultimately, the patient was definitively diagnosed with primary prostatic MALT lymphoma, Ann Arbor stage IE. He underwent external beam radiation therapy to the prostate, receiving a total dose of 3000 cGy delivered in 15 fractions. During radiotherapy, the patient experienced no significant adverse reactions. Following treatment, urinary obstruction symptoms markedly improved. Follow-up abdominal and urinary tract ultrasound examinations at 1week, 1month, and 4months post-radiotherapy showed marked tumor regression with no signs of recurrence. This report aims to share the treatment experience of this case, hoping to provide insights for clinicians.
같은 제1저자의 인용 많은 논문 (5)
- Synthesis, Evaluation, and First-in-Human Study of a Novel PSMA Radioligand Bearing Beta-Amino Acid Linkage.
- Effect of the surgical day of the week on postoperative outcomes of video-assisted thoracoscopic surgery for early-stage lung cancer patients: A multicenter cohort study.
- Advances in studying the role of SCARA5 in tumors.
- The ZNF737-CXCL10 axis drives immune exclusion and resistance to anti-PD-1 therapy in bladder cancer.
- Construction of a risk model based on exosome-related genes predict clinical prognosis and therapeutic response and revealing TIMP1 as a promising target in colorectal cancer.